Chronic liver disease-associated severe thrombocytopenia in Spain: Results from a retrospective study using machine learning and natural language processing

Calleja-Panero, Jose Luis; Mur, Rafael Esteban; Jarque, Isidro; Romero-Gómez, Manuel; García Labrador, Lucia; González Calvo, Jose.
Gastroenterol. hepatol. (Ed. impr.) ; 47(3): 236-245, mar. 2024.
Artigo Inglês | IBECS (Espanha) | ID: ibc-231204

Documentos relacionados

  1. Chronic liver disease-associated severe thrombocytopenia in Spain: Results from a retrospective study using machine learning and natural language processing.
  2. Management of chronic liver disease-associated severe thrombocytopenia in Spain: a view from the experts.
  3. Repeated Lusutrombopag Treatment for Thrombocytopenia in Patients with Chronic Liver Disease.
  4. Lusutrombopag is effective and safe in patients with chronic liver disease and severe thrombocytopenia: a multicenter retrospective study.
  5. Avatrombopag for the management of thrombocytopenia in patients with chronic liver disease.
  6. Management of Thrombocytopenia in Patients with Chronic Liver Disease.
  7. Innovative non-targeted liquid chromatography fingerprinting approach for authenticating tigernuts under Protected Designation of Origin quality seal.
  8. [Shared electronic health record in Catalonia, Spain].
  9. [Management strategies for chronic liver disease-related thrombocytopenia].
  10. Microangiopatías trombóticas en niños críticamente enfermos. Registro español MATUCIP